Kalshi opens prediction market for biopharma trial success, FDA approvals

Kalshi, a prediction market platform, is launching markets for biopharma companies to offer stakes on clinical trial outcomes and FDA approvals. This allows investors to bet on the success or failure of specific drug developments, potentially giving early signals on future treatments. It's bringing the world of betting to drug development, changing how we might forecast what's coming next in medicine.